1. Introduction {#sec1}
===============

Duplications leading to functional disomy of chromosome Xq28 are associated with a distinct clinical phenotype in males, characterized by severe mental retardation, infantile hypotonia, progressive neurologic impairment, recurrent infections, bladder dysfunction, and absent speech (see [@bib1] and [@bib2] for reviews). This combination of features is known as the Xq28 microduplication syndrome or Lubs syndrome and was first described by Pai et al. and Lubs et al.[@bib3; @bib4], followed by many others. The reported Xq28 duplications vary in size and location, however the majority are intrachromosomal duplications ranging from 0.3 to 2.3 Mb. Alternatively, duplications may be the result of another mechanism, such as rearrangements between Xq and Xp, or between Xq and the Y chromosome [@bib5]. The methyl-CpG binding protein (*MECP2*) gene on Xq28 is proposed to be the critical dosage-sensitive gene responsible for the severe phenotypes observed in patients with this duplication. In males, over 140 cases of Xq28 duplications including *MECP2* have been described to date [@bib5; @bib6; @bib7; @bib8; @bib9; @bib10; @bib11; @bib12; @bib13; @bib14; @bib15; @bib16; @bib17; @bib18; @bib19; @bib20; @bib21; @bib22; @bib23; @bib24].

Female patients with an Xq28 duplication are rare. In families with X-linked pedigrees, female carriers of an Xq duplication are usually asymptomatic, due to skewed X-chromosome inactivation (XCI) pattern with preferential inactivation of the rearranged chromosome. Until recently, only three symptomatic females had been reported with large, cytogenetically visible Xq28 duplications (summarized in [@bib21]). Clinically, these females presented with severe developmental delay and other features similar to those observed in affected males. In all cases the duplication was the result of an unbalanced X-autosome translocation, explaining the absence of skewing of the aberrant X-chromosome and the effect on the phenotype. After introduction of array CGH analysis, smaller, submicroscopic duplications of this region on Xq28 have been detected in four females, all in combination with random XCI [@bib25; @bib26; @bib27]. The patient with a *MECP2* duplication described by Ariani et al. [@bib28] should not be included in this series, as the patient turned out to have a 47,XXX karyotype (F. Ariani, personal communication). Based on this small series, it was concluded that in females with *MECP2* duplication and random XCI, the typical symptoms of affected boys are not present [@bib26]. Instead, the clinical signs in female patients consist of unspecific mild to moderate mental retardation, combined with variable symptoms (autistic features, recurrent infections in early childhood, constipation, and late-onset neurological features). Recently, a girl with a *de novo* complex X-chromosomal rearrangement was described, with a triplication of a fragment containing *MECP2*. She was severely mentally retarded and had seizures, but no other symptoms as seen in boys with a duplication [@bib29].

Here we present clinical and molecular data on a series of five females with an Xq28 duplication including the *MECP2* gene and these are compared with the previously reported cases of small duplications in females. In patient 1, a *MECP2* duplication was the result of a rare insertion duplication of a small segment of Xq28 into an autosome. Patients 2 and 3 are functionally disomic for region Xq28 due to an unbalanced X-autosome translocation. The fourth patient is a mildly affected obligate carrier from an X-linked mental retardation (XLMR) family. We detected a familial, intrachromosomal Xq duplication including *MECP2* in her, but unlike previously reported carrier females in X-linked families, she showed random X-inactivation. Patient 5 carries a small intrachromosomal *de novo* duplication of Xq28, including *MECP2*. In contrast to the previously reported series of affected females, our series includes a female patient with the typical symptoms of affected boys, therefore expanding the phenotypic spectrum of small Xq28 duplications including *MECP2* in females.

2. Methods {#sec2}
==========

2.1. Patients {#sec2.1}
-------------

Patients were evaluated in a diagnostic setting because of mental retardation (in the family). Standard karyotyping was performed by G-banding. Genomic DNA was extracted from whole blood using standard procedures.

2.2. Array platforms {#sec2.2}
--------------------

Duplications were either characterized by Affymetrix Genome-Wide SNP Array 6.0 (Affymetrix Inc, Santa Clara, California, USA; Patients 1 and 5) or Agilent 44K array (Agilent, Santa Clara, California, USA; patient 2 and 3) according to the manufacturer\'s instructions. The array design for patient 2 was modified for constitutional cytogenetic applications (see design specification at: <http://www.ngrl.org.uk/wessex/arraycgh.htm>). Data analysis was carried out with Genotyping Console 3.0.2 (patient 1) or Agilent\'s Analytics (patient 2 and 3). Patient 4 was characterized using an X-chromosome specific tiling-path array as described previously [@bib30].

2.3. Multiplex Ligation Probe Amplification (MLPA) {#sec2.3}
--------------------------------------------------

MLPA was performed with a specific kit for Rett syndrome (Salsa P015, MRC Holland, Amsterdam, The Netherlands) according to the manufacturer\'s instruction. Data analysis was performed with GeneMarker software (Softgenetics, USA).

2.4. Fluorescent In Situ Hybridisation (FISH) {#sec2.4}
---------------------------------------------

FISH analysis was carried out by standard procedures, using BAC clones selected within the duplicated and deleted regions (patients 1, 2, 5) and TelVision subtelomeric Xq probe (Vysis) (patient 3).

2.5. X-inactivation studies {#sec2.5}
---------------------------

In patients 1, 2, 4, and 5, X-chromosome inactivation was studied using the highly polymorphic small tandem repeat within the human androgen receptor gene, as described by Allen et al. [@bib31]. Inactivation was considered to be random if the ratio of active to inactive X was less than 75:25. Extreme skewing of X inactivation was defined as the preferential inactivation of one X chromosome in 90--95% of cells [@bib32].

3. Results {#sec3}
==========

[Table 1](#tbl1){ref-type="table"} provides a summary of the cytogenetic and phenotypic characteristics on five female patients with a *MECP2* duplication. All patients showed a normal karyotype by G-banding.

3.1. Case reports {#sec3.1}
-----------------

*Patient 1* is a 10-year old girl, first born to a 24-year old mother and a 25-year old father. Parents are healthy and non-consanguineous. The maternal grandfather developed epilepsy around the age of 40 years, otherwise the family history is unremarkable.

The patient was born at term with a birth weight of 3040 g (−1 SDS). Apgar scores were 8 and 10 at 1 and 5 min, respectively.

It was noted early on that her neuromotor development was slow (rolling over at 10 months of age, standing and walking a few steps (both with support) at the age of 3.5 years). She developed no speech. In the first year of life she made little contact, but this improved gradually and she became a friendly, sociable girl. She disliked changes in daily routine and loved spinning toys.

Her health is severely compromised. She had noisy breathing from birth on and laryngoscopy at the age of 2.5 years showed laryngomalacia. In infancy she was repeatedly admitted because of recurrent infections (at 7 years of age she had had several episodes of pneumonia (13 times), otitis media (five times), and pyelonephritis (twice)). She had surgery for reimplantation of the right urether. Her deciduous teeth did not fall out spontaneously, resulting in a double row of teeth, and had to be removed surgically.

At the age of 8 years and 2 months she was operated because of a luxation of the right hip and a subluxation of the left hip. Afterwards her condition deteriorated, she lost the ability to crawl and to walk with support. At the age of 8.5 years she developed febrile convulsions, followed by seizures and she was diagnosed with Lennox--Gastaut type of epilepsy, with a poor response to medical treatment. She has severe constipation, sleeping problems (refusing to go back to sleep after waking up in the middle of the night), and feeding problems (unable to eat solid food). She had a nasogastric tube for fluid, extra feeding and medication. At the age of 10 years she needed a PEG tube. Placement was complicated and prolonged due to an aberrant position of the liver (ventral to the stomach).

At 8 years of age she was able to communicate using pictures, she has limited understanding of sign language. After the hip surgery and development of epilepsy she lost most of these abilities. Also from that time on, parents noted loss of appetite, loss of energy and reported her to be increasingly lethargic. She showed a delayed reaction to stimuli. She was hypersensitive to loud noise and sunlight.

IQ testing using Kent Infant Development Scale confirmed severe developmental delay and regression (at the ages of 18, 32, 68, and 108 months, her development was conform 7, 8, 12, and 9 months, respectively).

When first assessed at the age of 17 months, her head circumference was 50.5 cm (+2.3 SDS). She showed mild dysmorphic features: prominent broad and high forehead, thin curly hair, telecanthus and epicanthus, thin eyebrows, small nose, full cheeks, open mouth with everted lower lip, broad alveolar ridges, narrow palate, widely spaced teeth, slightly pointed ears, short neck and inverted nipples ([Fig. 1](#fig1){ref-type="fig"}a).

On examination at the age of 3 years and 7 months her height was 98 cm (−0.8 SDS), her weight 16.4 kg, (+0.7 SDS for height) and her head circumference 52.5 cm (+1.7 SDS). Most facial features had become more obvious, however her forehead had grown normal and her philtrum was short and prominent ([Fig. 1](#fig1){ref-type="fig"}b). She drooled constantly. Neurological examination showed axial and peripheral hypotonia and brisk tendon reflexes. She had no apparent breathing abnormalities.

On follow up at the age of 7 years ([Fig. 1](#fig1){ref-type="fig"}c) she could pull herself up to her knees and stand with support. She made stereotypic movements with her hands, with preserved hand function.

On follow up at the age of 9 years her height was 128 cm (−1.5 SDS), her weight was 25 kg (−0.5 SDS for height) and her head circumference 54.5 cm (+1.4 SDS). She had difficulty to sit unsupported. She had no scoliosis. She had a limitation of 20° in the extension of right hip and knee, for which she wears nightly splints.

A brain MRI at the age of 10 months showed mildly enlarged ventricles and prominent sulci, suggestive of mild brain atrophy. MRI was repeated at 4 years of age and showed a Dandy---Walker malformation and demyelination.

MLPA analysis of the *MECP2* gene showed a duplication of this gene. Subsequent SNP array analysis identified a 279 kb duplication on chromosome Xq28 and a 207 kb duplication on chromosome 3q25.33q26.1. The duplication on Xq28 encompasses eight protein coding genes including *MECP2*, *OPN1LW*, *TEX28P2*, *OPN1NW*, *TEX28P1*, *TEX28*, *OPN1NW2* and *TKTL1*. Parental analysis showed that both rearrangements occurred *de novo*. X-inactivation analysis unravelled a random-methylation (60:40). Additional FISH analysis showed that the Xq28 duplication has been inserted into chromosome 3, adjacent to the 3q25.33q26.1 duplication ([Fig. 2](#fig2){ref-type="fig"}a).

*Patient 2* is a currently 7-year old girl, born at term after an uneventful pregnancy with a birth weight of 2940 g (−1 SDS). Postnatally, she was diagnosed with laryngomalacia at 3 days of age, which improved with time.

She presented at the age of 2 years and 8 months with failure to thrive despite a good appetite (height 81 cm, −3.5 SDS; weight 10.6 kg, −2.4 SDS, −0.2 SDS for height), microcephaly (OFC 45.5 cm, −2.2 SDS), and developmental delay. She has had recurrent urinary tract infections, with no underlying abnormalities.

Her development was moderately delayed, with sitting at the age of 14 months and crawling at 22 months. She had no speech, although her level of understanding was thought to be better than her expressed speech. She had some repetitive behaviour (hair pulling, hand flapping, biting herself). She had sleeping problems (refused to go back to sleep after waking up in the middle of the night).

On examination she was microcephalic (head circumference 45.6 cm (−2.1 SDS). She had no apparent dysmorphic features, apart from prominent infraorbital fullness (the appearance is of very prominent 'bags' under her eyes) ([Fig. 1](#fig1){ref-type="fig"}d). She had repeated chest infections and a persistent cough.

She was seen for follow up at the age of 4 years and 6 months ([Fig. 1](#fig1){ref-type="fig"}e). She had started to walk at the age of 3 years and 9 months, she walked with a wide-based gait. She was smiling a lot and she might use 'mama, dada, and bye--bye' appropriately, but had no other words. Her repetitive behaviour was getting less as her communicating skills had increased. Her sleeping problems had not responded to melatonin. She was about to start at a normal school, with full time personal help.

Apart from a marginally elevated TSH, additional investigations were normal, including an EEG and a brain MRI.

Array CGH analysis showed a 1.69 Mb duplication on chromosome Xq28 and a 1.54 Mb deletion on chromosome 21q22.3. Confirmatory FISH experiments using tiling path BAC clones, showed that BAC clones RP11-119A22, RP11-103M23, and RP11-402H20 from the Xq28 region have been translocated to the distal long arm of one of the chromosomes 21 homologues. FISH analysis with specific clones from the distal 21q region, RP11-162F19 and RP11-71A7, confirmed the telomeric deletion of one of the chromosome 21 homologues. Consequently, this patient carries a cryptic unbalanced translocation between chromosomes X and 21, der(21)t(X; 21)(q28; q22.3). Studies of parental chromosomes showed that the rearrangement is *de novo* and occurred on the paternal chromosomes. X-inactivation analysis showed random-methylation (45:55).

*Patient 3* is a 6.5-year old girl, first child of non-consanguineous and healthy Caucasian parents. She was born at term after an uneventful pregnancy by caesarian section, due to breech presentation. At birth, weight was 2320 g (−1.5 SDS), length 47 cm (−1.0 SDS) and head circumference 33.5 cm (−0.5 SDS). Apgar scores were 8 and 9 at 1 and 5 min, respectively.

Her development was delayed: sitting at the age of 10 months, walking with ataxic gait at 24 months, babbling at 4 years. She had feeding difficulties and growth deficit. In infancy, she suffered from constipation. She had several episodes of upper airway infections (bronchitis, pneumonia, and tonsillitis) since the age of 7 months, as well as nocturnal apnea.

She was evaluated at the age of 5 years. She was moderately interactive and she had a sociable behaviour. On follow up at the age 6 years and 5 months she showed little interest in people. She had developed dystonic movements. On physical examination her height was 112 cm (−1.0 SDS) and weight 23 kg (+0.7 SDS). She was microcephalic (head circumference 48.1 cm, −2.0 SDS), with a round face, up-slanting palpebral fissures, severe bilateral ptosis of eyelids (also noted in her paternal grandmother), bilateral epicanthic folds, flat and wide nasal bridge, small and widely spaced teeth, normal hand and foot length, bilateral hallux valgus, and cutis marmorata. She walked with ataxic gait, did not speak and she made repetitive movements with her head (stretching upward).

A cerebral CT recorded at the age of 7 months showed a cyst of the septum pellucidum and cavum vergae. A brain MRI at 2 years and 7 months of age showed an immature aspect of cortical white matter, mainly in the frontal lobes. An EEG, recorded at the age of 4 years and 10 months showed slowing down of background rhythm. Endocrinological evaluation performed for her growth deficit showed hypothyroidism. CD4/CD8 ratio and the study of T-lymphocyte subpopulations were normal.

Array CGH analysis identified a chromosome X subtelomeric duplication of about 2.10 Mb ([Fig. 2](#fig2){ref-type="fig"}b). Confirmatory FISH experiments showed that the Xq28 region has been translocated to the short arm of one of the chromosomes 22 homologues. Studies of parental chromosomes showed that the rearrangement is *de novo*. The karyotype is 46,XX.ish der(22),t(X; 22)(q28; p13)(VAMP7+)dn.

*Patient 4* is a member of an X-linked mental retardation family. The index patient in this family ([Fig. 3](#fig3){ref-type="fig"}V-1; [Fig. 1](#fig1){ref-type="fig"}f) was included in a Spanish collaborative XLMR study. The duplication was identified by an X-chromosome array-CGH and previously published (case 5, pedigree E in [@bib30]). Subsequent attempts to study the complete family were in vain. The family consists of three known affected males in three generations ([Fig. 3](#fig3){ref-type="fig"}). Three other males died a few days after birth and were probably also affected. Only one branch of the family could be studied (III-6; IV-2; IV-3 and the index patient V-1). The aforementioned paper included few clinical details [@bib30]. A detailed description of the index is provided in the [Supplementary data](#appsec1){ref-type="sec"}, clinical details on his mother and grandmother are presented here. Clinical data from other family members are scarce, but confirm X-linked inheritance of severe mental retardation.

*Patient 4*, mother of the index patient (IV-3, [Fig. 3](#fig3){ref-type="fig"}) was born to healthy non-consanguineous parents. Pregnancy and delivery were uneventful. She was born at 39 weeks of gestation, birth weight 2850 g (−1.1 SDS), length 48 cm (−1.2 SDS), and OFC 32 cm (−1.7 SDS). During early childhood she did not show signs of developmental delay, speech development was normal. She had autistic features, interaction both with her mother and others was poor. She presented with learning difficulties at school and she could not finish primary school. Before having her son, psychiatric symptoms had become apparent (depression, compulsions). She is currently rather impulsive and has a strong and difficult character when she is upset. Her cognitive level is below average (IQ 84) and below the level in her family (see [Suppl. Table 1](#appsec1){ref-type="sec"} for Wechsler Adult Intelligence Scale (WAIS-III) results). She shows little interest in other people and she is unemployed. She lives with her mother.

On physical examination at 26 years of age her height was 162 cm (−0.3 SDS), weight was 68 kg (+1.2 SDS), and OFC 56.5 cm (+0.7 SDS). Apart from fifth finger clinodactyly she had no apparent dysmorphic features ([Fig. 1](#fig1){ref-type="fig"}g).

Patient 4\'s mother, grandmother of the index case (III-6) is healthy, with a cognitive level within the normal range (see [Suppl. Table 1](#appsec1){ref-type="sec"} for the results of formal testing). She takes care of her daughter and grandson. She reported not to be very skillful with her hands and to suffer from a panic disorder. On physical examination weight and height were within normal limits, OFC is 56.5 cm (+0.7 SDS). She had large ears. Apart from clinodactyly of fifth fingers and hyperextensible interphalangeal joints, no dysmorphic features were present ([Fig. 1](#fig1){ref-type="fig"}h).

Her son (IV-4) suffered from meningitis when he was 9 days of age. Subsequently he presented with severe mental retardation, he never developed speech although he was able to understand simple tasks. He walked independently at the age of 3 years despite ataxic gait. He presented progressive epilepsy at 11 years of age, had recurrent episodes of severe pneumonia and died when he was 15 years old due to a complicated respiratory infection.

MLPA confirmed the Xq duplication in the index patient ([Fig. 2](#fig2){ref-type="fig"}c) and identified the same duplication in his mother (patient 4, IV-3) and grandmother (III-6, [Fig. 2](#fig2){ref-type="fig"}c). X-inactivation studies in the mother, patient 4, showed random X-inactivation (63.3:36.7), whereas it showed skewed X-inactivation in the grandmother (88.2:11.8).

*Patient 5* is an 8-year old girl, first born to 29-year old parents. Maternal hypertension developed at 36 weeks of gestation. The girl was born at 38 weeks of gestation, weighing 3430 g (0 SDS), length 53.3 cm (+1.7 SDS) and with normal Apgar scores.

Apart from eczema, no health problems were noted in the neonatal period. At 6 months of age hypotonia and developmental delay became apparent. Neurological evaluation at the age of 18 months left this unexplained. Brain MRI and EEG were normal.

Her motor development was delayed (walking around 22 months of age), as was her speech development (first words around 3 years of age). At the age of 7 years she could speak in 5-word sentences, though she was at times difficult to understand. She was in a special needs class. She had difficulties with social interaction and with changes in her environment or routine. Formal assessment for autism could not diagnose autism spectrum disorder.

When first assessed in a genetics clinic at the age of 22 months, she had a history of recurrent otitis media. On physical examination, length was 82.2 cm (−0.5 SDS), weight 10.8 kg (−1.0 SDS), and head circumference 47.7 cm (+0.5 SDS). Apart from slight epicanthal folds, there were no dysmorphic features. The skin revealed scattered patches of eczema. There was muscular hypotonia.

On follow up at the age of 7 years, she had a history of chronic constipation and chronic ear infections. On examination, her height was 121.8 cm (−0.5 SDS), her weight was 23 kg (−0.2 SDS), and her head circumference was 53.3 cm (+1.0 SDS). She had no apparent dysmorphic features.

Family history is unremarkable, her younger sister is doing well without concern for any delays.

SNP array analysis detected a 107.5 kb duplication on Xq28 and an 824.5 kb duplication on chromosome 2q23.1--q23.2. FISH experiments with BAC clone RP11-119A22 confirmed the duplication on the X chromosome. X inactivation studies showed skewing, though not complete (84:16). Parental analyses showed that the phenotypically normal father carried the 2q23 duplication, the Xq28 rearrangement is *de novo*.

In summary, all females described in this study had mental retardation or learning difficulties ([Table 1](#tbl1){ref-type="table"}). Accompanying features were mixed, but speech delay and recurrent infections were frequent symptoms. Notably, patient 1 had the most features as usually seen in affected boys.

Array CGH data are summarized in [Table 2](#tbl2){ref-type="table"} and [Fig. 4](#fig4){ref-type="fig"}.

4. Discussion {#sec4}
=============

We describe a series of five females carrying a submicroscopic Xq28 duplication involving *MECP2*. Whereas the phenotypic effect of a *MECP2* duplication is already well documented in males, it is a comparatively rare cause of mental retardation in females. In a recent paper, only two cases out of 1000 unselected patients with mental retardation were identified [@bib26]. Though females with large Xq28 duplications have been documented (as the results of X-autosome translocations, summarized in [@bib21]), only after introduction of array techniques were females with small *de novo* duplications including *MECP2* reported [@bib25; @bib26; @bib27]. In addition, two affected carrier females in X-linked families have been reported [@bib15; @bib20]. Our series is compared with published cases in [Table 1](#tbl1){ref-type="table"}, array data (where available) are summarized in [Fig. 4](#fig4){ref-type="fig"}. As can be deduced from [Fig. 4](#fig4){ref-type="fig"}, the minimal critical region in this series of females contains only the *MECP2* gene, confirming its role in mental retardation in females.

Previously, it has been stated that females with a (*de novo*) *MECP2* duplication lack the typical symptoms of affected boys, such as seizures, poor speech development, and recurrent severe infections ([@bib26], [Table 1](#tbl1){ref-type="table"}). Several females in our series however, do have poor speech development and patient 1 has recurrent severe infections. Furthermore, as patient 1 in our series only developed seizures after the age of 8 years, the younger patients with a *de novo* duplication may still be at risk of developing this feature. Compared to the compiled data in affected males with a *MECP2* duplication ([Table 1](#tbl1){ref-type="table"}), the course of the disease in patient 1 is strikingly similar, with regression after the start of seizures. Follow-up of patient 3 indicated also regression. Based on our data, we conclude that the associated phenotype in females with a *MECP2* duplication may be as severe as seen in affected males.

In our series, several mechanisms were found that resulted in functional disomy for region Xq28: i.e. X-autosome translocation, duplication (either familial or *de novo*) on the X-chromosome combined with random X-inactivation, and insertion duplication into an autosome.

4.1. X-autosome translocations {#sec4.1}
------------------------------

In unbalanced X-autosome translocations, the translocated segments will escape X-inactivation and cause functional disomy for genes contained within the translocated segments. In our series, patients 2 and 3 carry an unbalanced X-autosome translocation, as does the case described by Auber et al.[@bib25]. Previously reported X-autosome translocations have been excluded from the comparison as duplicated regions were either very large (∼16 Mb) or undefined [@bib21]. Patients in this group show various phenotypes, ranging from apparently mild mental retardation in patient 2 to a more severe clinical course in patient 3, with regression, loss of attention and emerging dystonic and repetitive movements, to a clinical picture that is comparable with the male Xq28 duplication syndrome in the patient described by Auber et al. [@bib25]. As the concurrent imbalance in these X-autosome patients is most likely of minor significance (see below), the phenotype is most likely determined by the Xq duplication. In this small series, the size of the Xq duplication appears to correlate with the severity of the clinical course.

4.2. Intrachromosomal Xq duplications; familial and *de novo* {#sec4.2}
-------------------------------------------------------------

Our series contains one female carrying a familial Xq duplication including *MECP2.* Patient 4 is a mildly affected obligate carrier from an X-linked mental retardation (XLMR) family. Previously reported families demonstrated asymptomatic carriers with extreme or complete skewing of X-chromosome inactivation. Unlike previously reported carrier females however, patient 4 showed random X-inactivation. Taking only her IQ score into account, she is not mentally retarded, yet she has notable learning difficulties and a striking difference in IQ compared to her mother. We hypothesize that this difference in performance is caused by the difference in XCI in mother and daughter (88:12 versus 63:37) and that the clinical features in patient 4 are caused by random X-inactivation. Previous papers lend support to this view. Recently, Reardon et al. [@bib20] reported a manifesting carrier with skewed X-inactivation in the ratio of 70:30. She had non-specific developmental delay, without seizures, speech problems, or recurrent infections. Furthermore, Kirk et al. [@bib15] describe a manifesting carrier with mild learning disability who had a mosaic X-inactivation pattern: in blood she showed complete skewing, however in hair roots XCI was random (74:26). It has been suggested that a 70% skewing or less will lead to manifestation of the disease in female carriers of a familial Xq duplication [@bib20]. Data on our patient support this hypothesis and indicate that the resulting phenotype is probably mild.

On the other hand, in a recent study focused on clinical and neuropsychiatric phenotype of *MECP2* duplication carriers, three out of nine female carriers of a familial *MECP2* duplication had IQs in the low normal range [@bib19]. Female carriers also had psychiatric symptoms, including anxiety, depression, and compulsion, despite 100% skewing of X-inactivation in blood. In comparison, the phenotype of patient 4 may fit into the clinical spectrum depicted in that paper, indicating that low normal IQ and psychiatric symptoms may be part of the clinical spectrum in female carriers, regardless of their XCI status. Alternatively, as X-inactivation pattern has only been tested in blood, the females with low scores in Ramocki\'s series may in fact have mosaic XCI, leading to tissue-specific dosage alterations, and probably to poor performance. A final conclusion awaits further studies.

A separate group is formed by patients with a *de novo* intrachromosomal *MECP2* duplication. It has been suggested previously that in these cases random XCI may be causative for the phenotype [@bib20]. To date, two females with a *de novo* Xq duplication of this type and random XCI have been reported, revealing moderate mental retardation in childhood and development of neurological features in the second decade [@bib26]. Patient 5 in our series also belongs to this category. As she is symptomatic, we assumed random XCI in her. Analysis in blood however showed skewed X-inactivation, though not complete (84:16). This may indicate that skewing needs to be complete to avoid a phenotypic effect of an Xq duplication. The XCI in patients 4\'s mother does not support this presumption, as she is normal functioning despite incomplete skewing (88:12). Alternatively, the phenotypic effect in patient 5 may be caused by an unfavourable skewing pattern, leading to preferential inactivation of the normal X chromosome, or by a mosaic XCI pattern, with random XCI in other tissues.

With regard to the mechanism of preferential X-inactivation, it has been suggested that co-duplication of neighbouring genes (i.e. *ARD1A* or *HCFC1*) may be responsible for complete skewing of X-inactivation in female carriers of an Xq28 duplication [@bib29]. Consequently, smaller deletions would thus result in random X-inactivation. Again, the XCI patterns in patient 4 and her mother do not support this hypothesis, as the same duplication, including the aforementioned genes, leads to either random XCI or almost extreme skewing in members of the same family.

4.3. Insertion duplication into an autosome {#sec4.3}
-------------------------------------------

Recently, Makrythanasis et al. [@bib27] reported a patient with an insertion duplication of a small segment of Xq28 into an autosome, causing a short segment on the X-chromosome to escape X-inactivation. Also the additional copy of *MECP2* in patient 1 is inserted into an autosome and therefore constitutionally active. Yet the clinical course of both patients is completely different: the patient described by Makrythanasis et al. is mildly affected, whereas the course of the disease in patient 1 is comparable to that in males, with regression after the start of seizures. We have no explanation for this discordance, however a difference in expression level may be postulated. It has been demonstrated in males that a triplicated *MECP2* gene resulted in the most severe phenotype [@bib11; @bib33]. Recently, a severely mentally retarded girl with a triplication including *MECP2* was described, suggesting a phenotypic effect of copy number [@bib29]. Also, in mice higher MeCP2 protein levels lead to more severe phenotypes [@bib34]. Therefore, it may be speculated that the difference in phenotype between the two insertion/duplication cases is caused by different levels of expression, for instance because the translocated *MECP2* gene in patient 1 has been coupled to a strong promotor, thus enhancing the MeCP2 level.

On the other hand, expression studies in males have shown that *MECP2* mRNA levels do not correlate with disease severity [@bib19]. Alternatively, under the influence of another promotor, transcription of the translocated *MECP2* gene may have been silenced in the patient described by Makrythanasis [@bib27].

As yet, the various mechanisms do not correspond to a distinct clinical phenotype, only familial duplications with random X-inactivation seem to result in a mild phenotype ([Table 1](#tbl1){ref-type="table"}).

In addition to the Xq duplication, three patients in our series showed an imbalance of another chromosome region ([Table 1](#tbl1){ref-type="table"}). In patient 1, a *de novo* duplication of 3q on the site of the insertion of Xq in the long arm of chromosome 3 was found. The duplicated region contains one gene, *IL12A.* To our knowledge no phenotype has been demonstrated for a duplication of this gene, but clinical relevance cannot be excluded. As a result of an unbalanced X-autosome translocation, patient 2 is also monosomic for distal 21q. The contribution of the deleted genes from this region to her phenotype is probably negligible, as larger distal 21q deletions have been described without phenotypic effect [@bib35]. In patient 5, the additional duplication was inherited from her phenotypically normal father, therefore indicating a most probably rare polymorphism. Gene content of additional CNVs in patient 1, 2 and 5 is listed in [Suppl. Table 2](#appsec1){ref-type="sec"}. Interestingly, second *de novo* imbalances were also found in previously reported patients ([@bib26; @bib27], see [Table 1](#tbl1){ref-type="table"}). In both cases, an association between the additional imbalance and the clinical phenotype was deemed unlikely.

Many authors have stressed the recurrent infections in males with Xq duplications ([Table 1](#tbl1){ref-type="table"}). Smyk et al. have suggested that they result from increased *IRAK1* dosage [@bib22]. Our data do not support this hypothesis, as in patient 1 *IRAK1* is not included in the duplicated fragment, yet she has a typical pattern of recurrent infections as seen in boys with a *MECP2* duplication. As none of the other duplicated genes in the region are associated with recurrent infections, this clinical course suggests that this symptom can be attributed to duplication of the *MECP2* gene.

In summary, an Xq duplication including *MECP2* is described in five females with various grades of developmental delay. With our series of *MECP2* duplication carriers we have extended the spectrum of the associated phenotype in females. We conclude that a duplication of *MECP2* may be associated with a severe phenotype in both males and females. Especially *de novo* duplications that escape X-inactivation may be associated with a severe clinical outcome in females. The phenotype of intrachromosomal duplications of this region is more difficult to predict and may be mild. However, the highly variable clinical presentation makes genetic counselling in terms of prognosis difficult, especially in prenatal cases. It has been postulated that carriers of a familial *MECP2* duplication may express a phenotype if X-inactivation is not completely skewed. Our data provide additional evidence for this hypothesis. Further studies of more females with a *MECP2* duplication are needed to gain better insight in the clinical variability and into the potential pathology associated with rearrangements in this area.

Appendix A. Supplementary material {#appsec1}
==================================

The following are the Supplementary material related to this article:
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![Phenotypical characteristics of individuals with an Xq28 duplication including *MECP2*. a-c. patient 1, aged 1 year and 5 months (a), 3 years and 7 months (b) and 7 years (c). Note facial hypotonia, large mouth, and widely spaced teeth. d,e. patient 2, aged 2 years and 8 months (d) and 4 years and 6 months (e). f. Index patient in the described XLMR-family, his mother, patient 4 (g) and grandmother (h). Overall, patients show no common facial features, though patient 2 (c,d) and the index patient in the described XLMR-family (f) show almost identical prominent infraorbital fullness.](gr1){#fig1}

![Illustration of Xq duplication of the *MECP2* region. a. FISH analysis in patient 1. The Xq duplication (RP11-333O06; red) is inserted in the long arm of chromosome 3 (black arrow), coinciding with the 3q duplication (RP11-67F24; green). Control probes: centromere chromosome 3 (a-sat 3, Cytocell; green) and centromere chromosome X (pBamX5; red). b. Array-CGH ratio profile in patient 3. Chromosome X array CGH ratio profile using DNA from the patient and a reference DNA from a normal female. On the left, the chromosome X ideogram. On the right, the log2 ratio of the chromosome X probes plotted as a function of chromosomal position. Each dot represents a single probe (oligo) spotted on the array. Oligos with a value of zero represent equal fluorescence intensity ratio between sample and reference. c. MLPA profiles showing an Xq duplication in family 4. Graphical representation of MLPA data (left panel, index patient; right panel, maternal grandmother), showing the bars of the duplicated Xq region in red (from *SLC6A8* to *OPN1MW* including all *MECP2* exons). In the index, peak valuesreach 1.50, suggesting a duplication as normal dose is normalized to 0.75. In the grandmother, peak values of the duplication (bars in red) reach 1.25, as normal dose corresponds to two X chromosomes.](gr2){#fig2}

![Pedigree of X-linked mental retardation family (previously published as pedigree E in Madrigal et al., 2007[@bib30]). 49 y, age at last examination; d 15 y, died at the age of 15 years. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)](gr3){#fig3}

![Schematic representation of part of the Xq28 region. The location of the duplications of our five patients and five previously reported females is depicted. Due to missing data, the patient described by Kirk et al. [@bib15] could not be included. Pattern codes: vertical stripes, insertion of Xq into an autosome; solid bar, unbalanced X-autosome translocation; horizontal stripes, familial intrachromosomal Xq duplication; dotted, *de novo* intrachromosomal duplication of Xq, diagonal stripes, *de novo* intrachromosomal triplication of Xq. Arrow, minimal critical region. Gene content of the region is shown from the UCSC Genome Browser version Human March 2006 (NCBI36/hg18).](gr4){#fig4}

###### 

Comparison of genotype and phenotype in males and females with submicroscopic Xq28 duplications, including *MECP2*.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Case ID                                                       Males     Females                                                                                                                                        
  ------------------------------------------------------------- --------- -------------------- -------- ------------------ ------------- -------- ---------------- --------------- ---------------- --------- ---------- --------------
  Cytogenetic characteristics                                                                                                                                                                                            

  Size of Xq duplication                                                  3.81 Mb              129 kb   0.7 Mb (minimum)   266 kb        478 kb   300 kb           279 kb          1.69 Mb          2.10 Mb   700 kb     107.5 kb

  Chromosomal rearrangement[b](#tbl1fnb){ref-type="table-fn"}             t(X; A)              X → A    dup X              dup X         dup X    complex\         X → A           t(X; A)          t(X; A)   dup X      dup X
                                                                                                                                                  (trip X/dup X)                                                         

  Inheritance                                                             d.n.                 d.n.     familial           d.n.          d.n.     d.n.             d.n.            d.n.             d.n.      familial   d.n.

  Parental origin                                                                                       mat                pat           pat      pat                              pat                        mat        

  2nd alteration                                                          del 17p13.3 (d.n.)   --       --                 dup 2q37.3\   --       --               dup 3q (d.n.)   del 21q (d.n.)   --        --         dup 2q (pat)
                                                                                                                           (d.n.)                                                                                        

  X-inactivation                                                                               Random   70:30              39:61         29:71    75:25            65:35                                      63:37      84:16

  Clinical features                                                                                                                                                                                                      

  Age at last examination (y)                                             9 10/12              19       12                 7 6/12        20       7                9               4 6/12           6 5/12    26         7

  Mental retardation                                            141/142   \+                   \+       \+                 \+            \+       \+               \+              \+               \+        --         \+

  Learning difficulty                                                                                                                                                                                         \+         

  Hypotonia                                                     102/111   \+                   \+       --                                        --               \+              --               \+        --         \+

  Absent/delayed speech                                         82/93                          \+       --                 --            \+       \+               \+              \+               \+        --         \+

  Lack/loss of ambulation                                       32/90                          --       --                 --            --       --               \+              --               --        --         

  Recurrent infections                                          99/120    \+                   --       --                 \+            --                        \+              \+               \+        --         \+

  Breathing abnormalities                                       7/19      \+                   --                                                                  --              --               \+        --         

  Stereotyped hand movements                                    23/47     \+                   --                          --                     \+               \+              --                         --         

  Autistic features/autism                                      16/21                          --                          \+            \+                                        --               \+        \+         --

  Epilepsy                                                      65/132    \+                   --       --                 --            --       \+               \+              --               --        --         --

  GU abnormalities                                              29/67                                                                    \+                        \+              \+                         --         

  Death \< 25 y                                                 27/73                                                                                                                                         --         

  Spasticity                                                    46/76                          --       --                 --            \+                                        --                         --         

  Ataxia                                                        22/41                          --       --                                                                         \+               \+        --         

  GER                                                           18/31                                                                                                              --                         --         

  Swallowing difficulties/feeding problems                      29/57     \+                                                                                       \+              --               \+        --         

  IPO or constipation                                           33/45                          --                          \+            --                        \+              --               \+        \+         \+

  Dysmorphic features                                           53/57     \+                   --       --                 --            --       \+               \+              --               \+        --         --

  Laryngomalacia                                                                                                                                                   \+              \+                                    
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

d.n., *de novo*; +, present; --, absent (as stated in paper, or deduced from normal results); empty field, no data; mat, maternal; pat, paternal; GU, genitourinary; GER, gastoesophageal reflux; IPO, intestinal pseudo-obstruction.

based on the compiled data of affected males summarized in [@bib2] (*n* = 119) [@bib5], (*n* = 6) [@bib6], (*n* = 4) [@bib7], (*n* = 1) [@bib8], (*n* = 1) [@bib9], (*n* = 3) [@bib13], (*n* = 1), and [@bib20] (*n* = 7).

t(X; A), unbalanced X; autosome translocation; X → A, insertion of Xq into an autosome; dup X, intrachromosomal duplication of Xq; trip X, intrachromosomal triplication of Xq.

###### 

Summary of array results in patients with Xq28 duplications, including *MECP2*.

  Case ID (DECIPHER code)   Platform                         Chr            Starting probe   Ending probe   Start position   End position   Confirmation   Status of inheritance
  ------------------------- -------------------------------- -------------- ---------------- -------------- ---------------- -------------- -------------- -----------------------
  1 (LEI249115)             Affymetrix 6.0                   X              SNP_A-8289707    CN_919279      152944369        153229444      FISH           *de novo*
  3, dup                    SNP_A-8679270                    CN_1009211     161179692        161387072      FISH             *de novo*                     
  2 (WSX002126)             Agilent 44K                      X              A_14_P139931     A_14_P111123   152850692        154494649      FISH           *de novo*
  21, del                   A_14_P106169                     A_14_P100394   45354820         46892352       FISH             *de novo*                     
  3(SIE004469)              Agilent 44K                      X              A_14_P104261     A_14_111123    152417785        154494590      FISH           *de novo*
  4                         X-chromosome tiling-path array   X              RP11-54I20       CTD-2238E23    152359267        153108683      MLPA           X-linked
  5                         Affymetrix 6.0                   X              unknown          unknown        152914248        153021750      FISH           *de novo*
  2, dup                    unknown                          unknown        148878326        149702817                       paternal                      

Mapping positions are according to the hg18 assembly of the UCSC genome browser. Del, deletion; dup, duplication.
